SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Amazon entered into a material definitive agreement. The specific nature of the agreement—whether involving acquisition, disposition, merger, strategic partnership, or another material contract—cannot be determined from the limited disclosure provided.
View raw filing on EDGAR →Amazon created a direct financial obligation or off-balance sheet arrangement. The specific nature of the obligation—whether debt issuance, lease arrangement, contingent liability, or other financial commitment—cannot be determined from the limited disclosure provided.
View raw filing on EDGAR →Masimo completed a merger in which shareholders received $180.00 per share in cash consideration, resulting in Masimo becoming a wholly owned subsidiary of the acquirer. The merger involved automatic cancellation and conversion of common stock and equity awards, modification of security holder rights, amendment of governing documents, termination of a material credit agreement, and delisting from Nasdaq.
View raw filing on EDGAR →Six directors (Catherine Szyman, Michelle Brennan, Quentin Koffey, Wendy Lane, Tim Scannell, and Darlene Solomon) resigned from the board, and three named executives (Catherine Szyman, Gregory Meehan, and Charles Dadswell) resigned from employment, all effective at the merger closing date.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Lulu's Fashion Lounge's Annual Meeting of Stockholders held on June 9, 2026. The filing presents voting tallies for four proposals: election of two Class II directors (Anisa Kumar and Crystal Landsem), ratification of Deloitte & Touche LLP as auditor, approval of a certificate amendment reducing authorized shares, and approval of officer exculpation provisions. All proposals passed. Shareholder vote results are material to investors as they confirm governance outcomes and corporate actions approved by the shareholder base.
View raw filing on EDGAR →B&G Foods closed a $475 million senior notes offering on June 10, 2026, and entered into a material definitive agreement related to the offering. The company intends to use proceeds to redeem $509.3 million of existing senior notes due 2027, effectively refinancing its debt structure.
View raw filing on EDGAR →Voyager's stockholders approved the 2026 Annual Meeting matters, including election of three Class II directors (Geraghty, Hyman, Sandrock), an advisory vote on named executive officer compensation, ratification of Ernst & Young LLP as independent auditor, and an amendment to increase authorized shares from 125 million to 245 million total shares and from 120 million to 240 million common shares.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Grand Canyon Education's 2026 Annual Meeting of Stockholders held on June 10, 2026. The filing reports voting outcomes on four matters: election of six directors, approval of the 2026 Equity Incentive Plan, advisory approval of named executive officer compensation, and ratification of KPMG LLP as independent auditor. The detailed vote tallies (for, against, abstain, broker non-votes) for each proposal are the hallmark of Item 5.07 disclosures and constitute material information affecting investor understanding of corporate governance and shareholder sentiment.
View raw filing on EDGAR →Entrada Therapeutics held its Annual Meeting of stockholders on June 10, 2026, with shareholders voting on four proposals: election of two Class II directors (Peter S. Kim, Ph.D. and Bernhardt Zeiher, M.D.), ratification of Ernst & Young LLP as independent auditor, and approval of Amendment No. 1 to both the 2021 Stock Option and Incentive Plan and the 2021 Employee Stock Purchase Plan. All proposals passed with clear majorities.
View raw filing on EDGAR →Mark A. Talley was appointed as an Independent Trustee to fill a vacancy on the Board, with assignment to three committees. Jeffrey P. Somers resigned from the Board, but the filing's principal focus is on Talley's election and his qualifications and committee assignments.
View raw filing on EDGAR →Shareholders voted at the Annual Meeting to elect Ann M. Danner, William A. Lamkin, and Matthew P. Jordan to Class I of the Board for three-year terms, and ratified Deloitte & Touche LLP as the independent auditors for 2026, with specific vote tallies reported for each matter.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Virtu Financial's 2026 annual meeting held on June 10, 2026. The filing reports voting outcomes on three matters: election of Class II directors (Aaron Simons, Joseph J. Grano Jr., and Joanne M. Minieri), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All three items passed with substantial majorities, making this a routine but material governance disclosure required under Item 5.07.
View raw filing on EDGAR →The Board elected Elena B. Poptodorova as an Independent Trustee on June 9, 2026, increasing the Board size from seven to eight members and assigning her to the Audit, Compensation, and Nominating and Governance committees.
View raw filing on EDGAR →The Company's annual meeting of shareholders held on June 9, 2026 resulted in election of seven Trustees, approval of a non-binding advisory vote on named executive officer compensation, determination of frequency for future compensation advisory votes, and ratification of Deloitte & Touche LLP as independent auditors.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from Clean Energy Fuels' 2026 annual meeting held on June 10, 2026. The filing reports voting outcomes on three proposals: election of six directors, ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a routine but material governance disclosure.
View raw filing on EDGAR →Astrana Health held its Annual Meeting on June 10, 2026, with shareholders voting on four proposals: election of nine directors, ratification of Ernst & Young LLP as independent auditor, advisory approval of executive compensation, and approval of the amended 2024 equity incentive plan. The filing discloses detailed vote tallies for all proposals.
View raw filing on EDGAR →Argan Inc. held its 2026 Annual Meeting of Shareholders on June 10, 2026, with voting results on three matters: election of nine board members, non-binding say-on-pay approval, and ratification of Grant Thornton LLP as independent auditors.
View raw filing on EDGAR →Humacyte disclosed presentation of Phase 3 clinical trial results (V012) for its ATEV product in arteriovenous access for hemodialysis patients on June 10, 2026. While this is a significant clinical milestone for a medical device company, the disclosure does not fit neatly into the earnings_release category (which typically covers financial results) nor any other specific event type. The clinical trial readout is material to investors assessing the company's pipeline and regulatory prospects, warranting classification as other_material.
View raw filing on EDGAR →Shareholders approved and the Board adopted the 2026 Equity Incentive Plan, which amends the existing Omnibus Equity Incentive Plan and establishes the framework for future equity compensation grants to officers and directors, effective June 4, 2026.
View raw filing on EDGAR →Perpetua Resources held its 2026 Annual General Meeting of Shareholders on June 4, 2026, with all four proposals passing by substantial majorities: fixing the board at nine directors, electing nine directors (including Marcelo Kim, Christopher J. Robison, and Alexander Sternhell), approving the 2026 Equity Incentive Plan, and ratifying PricewaterhouseCoopers LLP as auditor.
View raw filing on EDGAR →The Company disclosed two material litigation matters: a putative securities class action (Barnes et al. v. Perpetua Resources Corp.) where the court granted a motion to dismiss the amended complaint without prejudice, allowing a second amended complaint by July 3, 2026; and an environmental lawsuit relating to the Stibnite Gold Project where the court denied plaintiffs' preliminary injunction motion on May 29, 2026, with cross-motions for summary judgment and oral argument scheduled for June 24, 2026.
View raw filing on EDGAR →Iovance held its Annual Meeting of Stockholders on June 10, 2026, with certified voting results on seven proposals including director elections, executive compensation advisory votes, auditor ratification, equity plan amendments, and a certificate of incorporation amendment to increase authorized shares. All proposals passed.
View raw filing on EDGAR →Iovance received marketing authorization from Australia's Therapeutic Goods Administration for Amtagvi® in advanced melanoma on June 4, 2026. This regulatory approval is material to the company's commercial prospects and pipeline.
View raw filing on EDGAR →Swarmer entered into a Common Stock Purchase Agreement with Lucid Capital Markets on June 10, 2026, granting Lucid the right to purchase up to 3,000,000 shares of common stock at 98% of VWAP over a 24-month period. This is a classic at-the-market (ATM) or equity line of credit arrangement that creates significant dilution risk. The filing explicitly states the shares are offered in reliance on Section 4(a)(2) (private placement exemption), and the Company expects to use proceeds for operations and expansion. This is a material dilutive issuance typical of small-cap companies raising capital through equity lines.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of McEwen Inc.'s annual shareholder meeting held June 4, 2026. The filing presents voting tallies for three proposals: (i) election of eleven directors, (ii) ratification of Ernst & Young LLP as independent auditor, and (iii) approval of common stock issuance to Robert R. McEwen. All three proposals passed with substantial majorities, making this a material governance event that investors rely on to assess board composition and auditor continuity.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes on six proposals: election of five directors (Dr. Khalid Islam, Chris A. Rallis, Marco Brughera, Jodi Cook, Jeffrey Hackman), appointment of auditors (Haskell & White LLP), advisory votes on executive compensation and frequency thereof, amendments to the 2020 Equity Incentive Plan, and adoption of the 2026 Equity Inducement Plan. All proposals were approved by shareholders on June 10, 2026. This is material as it confirms governance and compensation decisions affecting the company's leadership and capital structure.
View raw filing on EDGAR →Factorial Energy Inc. completed a business combination with CGC, a special purpose acquisition company. The transaction involved entry into material definitive agreements (amended and restated registration rights agreement, warrant agreement, indemnification agreements, and equity incentive plans) and resulted in a change of control, with CGC domesticating as a Delaware corporation, changing its name to Factorial Energy Inc., and ceasing to be a shell company. The combined entity's Series A Common Stock and Public Warrants commenced trading on Nasdaq under ticker symbols FAC and FACWW.
View raw filing on EDGAR →Factorial Energy Inc. completed an unregistered sale of equity securities under Section 4(a)(2) of the Securities Act in connection with the business combination, resulting in significant share dilution with registration rights granted for 80.6 million shares representing 88.1% of outstanding shares.
View raw filing on EDGAR →Seven directors (Siyu Huang, Alex Yu, Joseph Taylor, Uwe Keller, Liad Meidar, Dieter Zetsche, and Jon Nelson) were appointed to the PubCo Board, and four named executive officers were appointed effective immediately following the merger: Siyu Huang as CEO, Richard Wei as CFO, Alex Yu as CTO, and Jason Duva as General Counsel and Secretary.
View raw filing on EDGAR →CBIZ was dismissed as the registrant's independent auditor on June 5, 2026, and RSM US LLP was engaged as the new auditor on the same date. The filing states there were no disagreements or reportable events between the registrant and CBIZ.
View raw filing on EDGAR →In connection with the business combination closing, the registrant adopted amended articles of incorporation and bylaws, including lock-up provisions affecting share transferability and governance changes, and adopted a new Code of Business Conduct and Ethics.
View raw filing on EDGAR →Prologis priced a ¥44.7 billion (~$280.6 million) offering of senior unsecured notes in three tranches (2030, 2035, and 2041 maturities) on June 4, 2026, with closing expected June 11, 2026. The proceeds will be used for debt repayment and general corporate purposes.
View raw filing on EDGAR →This disclosure furnishes preliminary assets under management (AUM) as of May 31, 2026 via a news release under Regulation FD. While AUM is a key operational metric for asset managers and would be material to investors assessing the registrant's business performance and client flows, it does not fit neatly into the more specific event categories (it is not an earnings release, M&A activity, executive change, or other defined event type). The disclosure is material but best classified as other_material.
View raw filing on EDGAR →The filing discloses an update on a previously-announced merger between TMTG and TAE Technologies, Inc., with a press release issued on June 10, 2026 providing material transaction details. The disclosure references a Form S-4 registration statement, proxy statement/prospectus, and merger agreement, all hallmarks of a material acquisition/change of control transaction that would substantially affect the registrant's business and capital structure.
View raw filing on EDGAR →Nuwellis announced the closing of a registered public offering that raised approximately $6,000,000 in gross proceeds and resulted in the exercise of pre-funded warrants, increasing outstanding shares to 12,750,321. This is a material equity issuance that dilutes existing shareholders and signals capital-raising activity typical of small-cap companies under financial pressure.
View raw filing on EDGAR →At the 2026 annual meeting of stockholders held on June 9, 2026, the Company's stockholders approved an amendment to the Amended and Restated 2010 Stock Incentive Plan to increase the aggregate number of authorized shares by 6,500,000 for employee compensation purposes.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Taboola's Annual General Meeting held on June 9, 2026. The filing reports voting outcomes on five proposals: director re-elections, advisory compensation vote, compensation policy approval, CEO compensation terms, and auditor re-appointment. All proposals passed by requisite majorities, making this a material governance event that affects investor understanding of shareholder approval and corporate oversight.
View raw filing on EDGAR →PCSC shareholders voted on June 10, 2026 to approve an amendment to the articles of association extending the deadline for completing an initial business combination from June 13, 2026 to June 13, 2027. The Extension Amendment Proposal passed with overwhelming support (8,515,798 for, 75 against, 4,866 abstain) at a quorum of 76.5% of voting power.
View raw filing on EDGAR →John Gehre was appointed as Chairman of the Board effective June 9, 2026. The appointment represents a material change to the company's governance and leadership structure.
View raw filing on EDGAR →Shareholders voted at the June 9, 2026 annual meeting on three proposals: election of six directors, ratification of Whitley Penn as independent auditor, and an advisory vote on executive compensation. All three proposals passed with substantial majorities.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of a special stockholder meeting held on June 10, 2026, where Kennedy-Wilson shareholders voted on three proposals: (1) adoption of the Merger Agreement with Kona Bidco, LLC (approved with 148,957,598 votes for vs. 535,978 against), (2) advisory compensation approval (approved 139,504,118 for vs. 9,411,306 against), and (3) adjournment proposal (approved 143,306,344 for vs. 6,169,767 against). The merger proposal approval is material as it enables the anticipated June 16, 2026 closing of a change-of-control transaction.
View raw filing on EDGAR →The filing discloses reaffirmation of full-year 2026 earnings guidance ($19.85 per diluted share including unfavorable items; $26.75 adjusted) and benefit expense ratio guidance (90.2% ± 50 bps) during investor meetings. While this is forward-looking guidance rather than an earnings release (which typically reports historical results), the reaffirmation of specific quantitative earnings and operational metrics would materially affect a reasonable investor's assessment of the company's expected financial performance. This does not fit cleanly into earnings_release (no historical results reported) but is material guidance disclosure that warrants classification as other_material.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of CME Group's 2026 Annual Meeting of Shareholders held on June 9, 2026 (reconvened from May 14 due to quorum issues). The filing details voting outcomes on five substantive proposals: elimination of Class B-1, B-2, and B-3 director election rights (Items 4–6); a certificate of incorporation amendment (Item 7); and election of Class B directors (Item 8). The disclosure includes vote tallies, percentages, and quorum determinations across multiple share classes, which is the core content of a shareholder vote results disclosure under Item 5.07.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the June 4, 2026 annual meeting of stockholders, covering three proposals: election of six directors, ratification of KPMG as independent auditors, and an advisory vote on executive compensation. The filing presents detailed vote tallies for each matter, which is the core content of Item 5.07 and constitutes a material event affecting corporate governance and board composition.
View raw filing on EDGAR →Ketan Seth resigned as Chief Executive Officer and director of Blue Acquisition Corp effective immediately on June 9, 2026. While the filing also discloses David Bauer's appointment as interim CEO on the same day, the principal disclosed action centers on the CEO's departure. For a SPAC, CEO resignation is material to investors assessing management continuity and the company's ability to identify and consummate a business combination.
View raw filing on EDGAR →The filing discloses J.Jill's financial results for the first quarter ended May 2, 2026, via a press release attached as Exhibit 99.1. This is a standard quarterly earnings announcement under Item 2.02, which is the canonical disclosure vehicle for earnings releases and would materially affect a reasonable investor's assessment of the company's financial performance and condition.
View raw filing on EDGAR →Cullinan Therapeutics disclosed updated Phase 1 clinical trial data for CLN-978 in rheumatoid arthritis and systemic lupus erythematosus, along with initial Phase 1b/2a data for velinotamig in SLE, demonstrating positive efficacy and safety signals including clinical remission in RA patients and rapid improvements in SLE biomarkers. This clinical progress represents material advancement of the company's pipeline that would affect a reasonable investor's assessment of the company's valuation and strategic direction.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Strategy Inc's 2026 Annual Meeting of Stockholders held on June 8, 2026, including voting outcomes on five proposals: election of eight directors, ratification of KPMG LLP as independent auditor, advisory vote on named executive officer compensation, ratification of preferred stock certificate amendments, and approval of dividend payment frequency changes. The detailed vote tallies (For/Against/Abstain/Broker Non-votes) for each proposal are the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →Fold Holdings disclosed a material transaction involving the monetization of $45 million in bitcoin and elimination of $20 million in debt, which would affect a reasonable investor's assessment of the company's liquidity, asset position, and leverage. While this does not fit neatly into the standard M&A, impairment, or covenant categories, the scale and nature of the transaction (significant asset liquidation and debt reduction) constitute a material event requiring disclosure under Regulation FD.
View raw filing on EDGAR →The filing discloses preliminary results from Medallion Financial Corp.'s 2026 Annual Meeting of Stockholders via press release. This is a direct disclosure of shareholder voting outcomes, which is material to investors as it determines board composition, executive compensation approvals, and other governance matters. The event matches the shareholder_vote_results taxonomy entry.
View raw filing on EDGAR →